Alzheimer's Disease

Alzheimer’s is most common type of dementia. Alzheimer’s is a chronic neurodegenerative disorder. Patient of Alzheimer’s shows early symptoms of short term memory and later progresses to problems in language, disorientation. Causes of Alzheimer’s are not clear yet, but 70% of risks are associated with genetics. There are no existing treatments to reverse or stop Alzheimer’s. Most of patients with Alzheimer’s are above 65 years of age but 4-5% cases are of early onset Alzheimer’s. It’s still one of the costly diseases. Alzheimer’s disease has been key topics in neurology conferences and dementia conferences. Separate Alzheimer’s conferences has been arranged to make aware world for its consequences. In 2016, hundreds of conferences has main topic as Alzheimer’s disease as it contributes to 60-70% cases of dementia. Several countries governments are taking initiative in Alzheimer’s congress such as UK, USA, Canada, France having high ratio of deaths due to Alzheimer’s patients and other dementias.
  • Track 1-1 Alzheimer's Disease pathophysiology and mechanisms
  • Track 2-2 Genetics in Alzheimer's Disease
  • Track 3-3 Risk factors: head injury, depression and hypertention
  • Track 4-4 Causes and preventions in Alzheimer's Disease
  • Track 5-5 Medication and diet for Alzheimer's Disease
  • Track 6-6 Symptoms of Alzheimer's Disease
  • Track 7-7 Brain imaging for Alzheimer's Disease
  • Track 8-8 Treatments for Alzheimer's Disease
  • Track 9-9 Cholinergic and amloid hypothesis in Alzheimer's
  • Track 10-10 Alzheimer's Disease associated complexities
  • Track 11-11 Clinical Trials for Alzheimer's Disease
  • Track 12-12 Recent advancements in Alzheimer's Disease
  • Track 13-13 Latest tests for detection of Alzheimer's Disease

Related Conference of Neuroscience